Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Guardant Health in India is seeking a Medical Lead to advance the company's precision oncology portfolio through strategic medical planning, evidence generation, and collaborative stakeholder engagement across oncologists, pathologists, labs, and academic centers.
Position focuses on local evidence generation, publication support, tumour board participation, and cross-functional medical input to inform country and regional strategy, with Delhi-area preference.
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant® is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn , X (Twitter) and Facebook .
The Medical Lead-India, will serve as Guardant Health's Medical Affairs representative for assigned territories within India, responsible for advancing clinical understanding and appropriate adoption of Guardant's precision oncology portfolio. This role will partner closely with oncologists, pathologists, molecular laboratories, academic centres, payers, distributors, and internal commercial and regional teams within the assigned territories to generate evidence, educate stakeholders, support clinical implementation, and contribute to the medical strategy for India.The role requires a balance of strategic medical planning and hands‑on execution, including evidence generation, KOL engagement, scientific education, publication support, tumour board participation, and cross‑functional medical input. The Medical Lead will also capture and communicate local medical insights to inform regional strategy, evidence planning, market access priorities, and clinical adoption initiatives.Location Preference: Northern India preferred, with a strong preference for candidates located in Delhi and surrounding areas .
This role offers the opportunity to help shape the adoption of precision oncology testing across India. The Medical Lead will play a critical role in building scientific confidence, generating locally relevant evidence, supporting clinical implementation, and expanding access to advanced cancer diagnostics for patients.
Contribute to country-level evidence gap analysis and co‑develop the India evidence and publication roadmap in alignment with AMEA and global Medical Affairs priorities. Develop territory‑specific medical plans that reflect local oncology care pathways, molecular diagnostics adoption, stakeholder needs, and evidence requirements. Identify, design, and support company‑sponsored studies, real‑world evidence initiatives, clinical utility projects, and investigator‑initiated studies in assigned territories. Support study feasibility, protocol review, site engagement, investigator discussions, timelines, milestone tracking, and risk mitigation. Support the development and quality review of abstracts, posters, manuscripts, congress submissions, and evidence packages. Partner with regional Medical Affairs and cross‑functional teams to ensure local evidence generation is scientifically robust, compliant, and aligned with business and patient access priorities.
Build and maintain trusted scientific relationships with oncologists, pathologists, molecular laboratories, academic institutions, cancer centres, payers, public health stakeholders, and other relevant experts within assigned territories. Develop and deliver scientifically rigorous educational content, including deep‑dive presentations, grand rounds, CME programs, advisory boards, tumour board discussions, and internal/external training sessions. Provide on‑site and virtual clinical support for complex case discussions, report interpretation, molecular tumour boards, and multidisciplinary meetings. Train external speakers, distributors, and internal teams on scientific topics, clinical evidence, testing pathways, and appropriate use of Guardant Health products. Capture, synthesize, and communicate medical insights from KOL interactions, conferences, advisory boards, tumour boards, and field activities to inform country and regional strategy.
Provide compliant, evidence‑based medical input to Commercial, Marketing, Client Services, Market Access, Regulatory, and distributor teams. Advise cross‑functional teams on clinical strategy, scientific messaging, value narratives, payer evidence requirements, customer education needs, and territory‑specific stakeholder dynamics. Provide medical review of scientific and promotional materials, ensuring alignment with clinical evidence, internal standards, applicable regulations, and company compliance requirements. Support distributor medical activities where relevant, including training, scientific oversight, field medical support, and alignment with Guardant Health standards. Partner with Mar